TABLE 2.

Efficacy Evaluated by RECIST and mRECIST Criteria After TACE-HAIC and c-TACE Treatments

	RECIST Criteria			mRECIST Criteria
	TACE-HAIC (n = 41)	c-TACE (n = 42)	P	TACE-HAIC (n = 41)	c-TACE (n = 42)	P
Complete response	0 (0.0%)	0 (0.0%)	1.000	2 (4.9%)	2 (4.8%)	1.000
Partial response	6 (14.6%)	1 (2.4%)	0.107	25 (61.0%)	3 (7.1%)	<0.001
Stable disease	32 (78.0%)	25 (59.5%)	0.069	11 (26.8%)	25 (59.5%)	0.003
Progressive disease	3 (7.3%)	16 (38.1%)	<0.001	3 (7.3%)	12 (28.6%)	0.012
Overall response	6 (14.6%)	1 (2.4%)	0.107	27 (65.9%)	7 (16.7%)	<0.001
Disease control	38 (92.7%)	23 (54.8%)	<0.001	38 (92.7%)	30 (71.4%)	0.012

P values were calculated using a 2-sided Chi-square test.

c-TACE, conventional transarterial chemoembolization; RECIST, response evaluation criteria in solid tumors; TACE-HAIC, transarterial chemoembolization-hepatic artery infusion chemotherapy.